Zobrazeno 1 - 10
of 11 169
pro vyhledávání: '"SALINGER, A."'
Autor:
Samira Merali, David H. Salinger, Maria Palmisano, Amy J. Sehnert, Neelima Thanneer, Hyunmoon Back, Julie D. Seroogy, Daniel D. Gretler, Amit Roy, Vidya Perera
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 9, Pp 1448-1461 (2024)
Abstract Mavacamten is the first cardiac myosin inhibitor approved by the US Food and Drug Administration for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). The phase III EXPLORER‐HCM (NCT03470545) study use
Externí odkaz:
https://doaj.org/article/2d97afb3b2c44e46bccc7c6593bb0036
Autor:
Peter Chang, Vidya Perera, David H. Salinger, Samira Merali, Neelima Thanneer, Hyunmoon Back, Julie D. Seroogy, Daniel D. Gretler, Amy J. Sehnert, Maria Palmisano, Amit Roy
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 9, Pp 1462-1475 (2024)
Abstract Mavacamten is a selective, allosteric, reversible cardiac myosin inhibitor that has been developed for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). A population pharmacokinetic (PopPK) model was dev
Externí odkaz:
https://doaj.org/article/eaceb752f6ca46f980e5f1d94592e26c
Autor:
Allison P. Salinger, Ellen Vermes, Jillian L. Waid, Amanda S. Wendt, Sarah J. N. Dupuis, Md Abul Kalam, Abdul Kader, Sheela S. Sinharoy
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Agency – including the sub-domains of intrinsic agency, instrumental agency, and collective agency – is a critical component of the women’s empowerment process. Self-efficacy (a component of intrinsic agency) may operate as
Externí odkaz:
https://doaj.org/article/72394eee52a4458893b2f6a173703856
Autor:
Merali, Samira1 (AUTHOR) samira.merali@bms.com, Salinger, David H.2 (AUTHOR), Palmisano, Maria1 (AUTHOR), Sehnert, Amy J.1 (AUTHOR), Thanneer, Neelima1 (AUTHOR), Back, Hyunmoon1 (AUTHOR), Seroogy, Julie D.1 (AUTHOR), Gretler, Daniel D.3 (AUTHOR), Roy, Amit1 (AUTHOR), Perera, Vidya1 (AUTHOR)
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Sep2024, Vol. 13 Issue 9, p1448-1461. 14p.
Autor:
Salinger, Tobias (AUTHOR)
Publikováno v:
Financial Planning. Nov2024, Vol. 54 Issue 9, p12-21. 10p. 2 Color Photographs, 1 Diagram, 1 Chart, 1 Graph, 1 Cartoon or Caricature.
Autor:
Bošković-Sekulić Jelena, Sekulić Igor, Džudović Boris, Subotić Bojana, Salinger Sonja, Matijašević Jovan, Kovačević Tamara, Mitevska Irena, Miloradović Vladimir, Nešković Aleksandar, Obradović Slobodan
Publikováno v:
Vojnosanitetski Pregled, Vol 81, Iss 5, Pp 310-317 (2024)
Background/Aim. Multidetector computed tomography pulmonary angiography (MCTPA) has emerged as the most suitable method for diagnosing acute pulmonary embolism (APE) in hemodynamically stable patients. In addition to its diagnostic role, MCTPA facili
Externí odkaz:
https://doaj.org/article/8482b5bacaac4c5e84775a72beaa261f
Autor:
Shivani Chandramohan, Allison P. Salinger, Amanda S. Wendt, Jillian L. Waid, Md. Abul Kalam, Maryann G. Delea, Dawn L. Comeau, Shafinaz Sobhan, Sabine Gabrysch, Sheela Sinharoy
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Gender-transformative public health programs often aim to address power inequities between men and women and promote women’s empowerment. However, to achieve transformative change, it is necessary to first identify the underlyin
Externí odkaz:
https://doaj.org/article/d9de814b88154dc7858eaccdbce1c786
Autor:
Salinger, M James, Diamond, Howard J, Bell, James, Behrens, Erik, Fitzharris, B Blair, Herod, Nicholas, McLuskie, Melissa, Parker, Amber K, Ratz, Hiltrun, Renwick, James, Scofield, Claire, Shears, Nick T, Smith, Robert O, Sutton, Phil J, Trought, Michael C T
Publikováno v:
Weather and Climate, 2023 Jan 01. 42(1), 18-41.
Externí odkaz:
https://www.jstor.org/stable/27226713
Autor:
Zorica M. Dimitrijevic, Branka P. Mitic, Danijela D. Tasic, Tamara Vrecic, Karolina Paunovic, Sonja Salinger
Publikováno v:
Medicina, Vol 60, Iss 11, p 1760 (2024)
Background and Objectives: Patients undergoing chronic hemodialysis (HD) are predisposed to both thrombotic and bleeding complications due to the complex interplay of end-stage renal disease (ESRD), cardiovascular comorbidities, and the routine use o
Externí odkaz:
https://doaj.org/article/2dc89e7dd244442d9e220dc337f4069a
Autor:
Boris, Dzudovic, Tamara, Simpson, Ivica, Djuric, Bojana, Subotic, Jovan, Matijasevic, Jelena, Dzudovic, Marija, Benic, Sonja, Salinger, Ljiljana, Kos, Tamara, Kovacevic-Preradovic, Irena, Mitevska, Srdjan, Kafedzic, Aleksandar, Neskovic, Bojan, Mitrovic, Bjanka, Bozovic, Nebojsa, Bulatovic, Vladimir, Miloradovic, Slobodan, Obradovic
Publikováno v:
In Current Problems in Cardiology April 2024 49(4)